Baylor Rbd Spike Protein
Lab Reagents
Human IgG antibody Laboratories manufactures the baylor rbd spike protein reagents distributed by Genprice. The Baylor Rbd Spike Protein reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact Spike RBD. Other Baylor products are available in stock. Specificity: Baylor Category: Rbd Group: Spike Protein
SARS-CoV-2 (COVID-19) Spike RBD Antibody |
|||
9087-002mg | ProSci | 0.02 mg | EUR 229.7 |
Description: Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus (1). The disease is the cause of the 2019–20 coronavirus outbreak (2). The structure of 2019-nCoV consists of the following: a Spike protein (S), hemagglutinin-esterease dimer (HE), a membrane glycoprotein (M), an envelope protein (E) a nucleoclapid protein (N) and RNA. Coronavirus invades cells through Spike (S) glycoproteins, a class I fusion protein. It is the major viral surface protein that coronavirus uses to bind to the human cell surface receptor. It also mediates the fusion of host and viral cell membrane, allowing the virus to enter human cells and begin infection (3). The spike protein is the major target for neutralizing antibodies and vaccine development (4). The protein modeling suggests that there is strong interaction between Spike protein receptor-binding domain and its host receptor angiotensin-converting enzyme 2 (ACE2), which regulate both the cross-species and human-to-human transmissions of COVID-19 (5). The recent study has shown that the SARS-CoV-2 spike protein binds ACE2 with higher affinity than SARS-CoV spike protein (6). |
SARS-CoV-2 (COVID-19) Spike RBD Antibody |
|||
9087-01mg | ProSci | 0.1 mg | EUR 594.26 |
Description: Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus (1). The disease is the cause of the 2019–20 coronavirus outbreak (2). The structure of 2019-nCoV consists of the following: a Spike protein (S), hemagglutinin-esterease dimer (HE), a membrane glycoprotein (M), an envelope protein (E) a nucleoclapid protein (N) and RNA. Coronavirus invades cells through Spike (S) glycoproteins, a class I fusion protein. It is the major viral surface protein that coronavirus uses to bind to the human cell surface receptor. It also mediates the fusion of host and viral cell membrane, allowing the virus to enter human cells and begin infection (3). The spike protein is the major target for neutralizing antibodies and vaccine development (4). The protein modeling suggests that there is strong interaction between Spike protein receptor-binding domain and its host receptor angiotensin-converting enzyme 2 (ACE2), which regulate both the cross-species and human-to-human transmissions of COVID-19 (5). The recent study has shown that the SARS-CoV-2 spike protein binds ACE2 with higher affinity than SARS-CoV spike protein (6). |
SARS-CoV-2 (COVID-19) Biotinylated Spike RBD Recombinant Protein |
|||
10-205 | ProSci | 0.1 mg | EUR 752.1 |
Description: The spike protein (S) of coronavirus (CoV) attaches the virus to its cellular receptor, angiotensinconverting enzyme 2 (ACE2). A defined receptor-binding domain (RBD) on S mediates this interaction.The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity. |
SARS-CoV-2 (COVID-19) Spike RBD + SD1 Recombinant Protein |
|||
10-304 | ProSci | 0.1 mg | EUR 632.4 |
Description: SARS-CoV-2 (COVID-19) Spike RBD + SD1 Recombinant Protein |
SARS-CoV-2 (COVID-19) Spike RBD domain Recombinant Protein |
|||
20-232 | ProSci | 0.1 mg | EUR 726.9 |
Description: SARS-CoV-2 (COVID-19) Spike RBD domain Recombinant Protein |
Human CellExp™ SARS-CoV-2 Spike Protein (RBD), Recombinant |
|||
P1530-10 | Biovision | 10 µg | EUR 187.2 |
Human CellExp™ SARS-CoV-2 Spike Protein (RBD), Recombinant |
|||
P1530-50 | Biovision | 50 µg | EUR 709.2 |
Recombinant SARS Coronavirus Spike (RBD) Protein (aa 306-527) [His] |
|||
VAng-Wyb7338-100g | Creative Biolabs | 100 µg | EUR 2096.4 |
Description: severe acute respiratory syndrome coronavirus (isolate:WH20) Spike protein, recombinant protein. |
Recombinant SARS Coronavirus Spike (RBD) Protein (aa 306-527) [His] |
|||
VAng-Wyb7338-20g | Creative Biolabs | 20 µg | EUR 753.6 |
Description: severe acute respiratory syndrome coronavirus (isolate:WH20) Spike protein, recombinant protein. |
Recombinant SARS Coronavirus Spike (RBD) Protein (aa 306-527) [His] |
|||
VAng-Wyb7338-50g | Creative Biolabs | 50 µg | EUR 1326 |
Description: severe acute respiratory syndrome coronavirus (isolate:WH20) Spike protein, recombinant protein. |
Recombinant SARS Coronavirus Spike (RBD) Protein (aa 306-527) [Fc] |
|||
VAng-Wyb7339-100g | Creative Biolabs | 100 µg | EUR 2096.4 |
Description: severe acute respiratory syndrome coronavirus (isolate:WH20) Spike protein, recombinant protein. |
Recombinant SARS Coronavirus Spike (RBD) Protein (aa 306-527) [Fc] |
|||
VAng-Wyb7339-20g | Creative Biolabs | 20 µg | EUR 753.6 |
Description: severe acute respiratory syndrome coronavirus (isolate:WH20) Spike protein, recombinant protein. |
Recombinant SARS Coronavirus Spike (RBD) Protein (aa 306-527) [Fc] |
|||
VAng-Wyb7339-50g | Creative Biolabs | 50 µg | EUR 1326 |
Description: severe acute respiratory syndrome coronavirus (isolate:WH20) Spike protein, recombinant protein. |
SARS-CoV-2 Spike S1 RBD Protein, Avi-His-tag |
|||
E80024-1 | EpiGentek | 100 ul | EUR 635.8 |
SARS-CoV-2 Spike S1 RBD Protein, Avi-His-tag |
|||
E80024-2 | EpiGentek | 1 ml | EUR 4995.1 |
SARS-CoV-2 Spike S1 RBD Protein, Mouse Fc-fusion |
|||
E80026-1 | EpiGentek | 20 ul | EUR 588.5 |
SARS-CoV-2 Spike S1 RBD Protein, Mouse Fc-fusion |
|||
E80026-2 | EpiGentek | 50 ul | EUR 823.9 |